1. Home
  2. PRDO vs RAPP Comparison

PRDO vs RAPP Comparison

Compare PRDO & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$32.77

Market Cap

2.2B

Sector

Real Estate

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$39.32

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
RAPP
Founded
1994
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
1997
2024

Fundamental Metrics

Financial Performance
Metric
PRDO
RAPP
Price
$32.77
$39.32
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$42.00
$48.50
AVG Volume (30 Days)
524.5K
290.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
1.75%
N/A
EPS Growth
10.50
24.34
EPS
0.85
N/A
Revenue
$581,296,000.00
N/A
Revenue This Year
$4.28
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$38.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.66
$8.20
52 Week High
$38.50
$42.27

Technical Indicators

Market Signals
Indicator
PRDO
RAPP
Relative Strength Index (RSI) 37.25 61.52
Support Level $32.14 $25.48
Resistance Level $32.79 $41.33
Average True Range (ATR) 0.96 2.08
MACD -0.14 0.18
Stochastic Oscillator 2.31 84.38

Price Performance

Historical Comparison
PRDO
RAPP

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Share on Social Networks: